Cochrane Abstracts
Mesalamine (5‐ASA) for the prevention of recurrent diverticulitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mesalamine (5‐ASA) for the Prevention of Recurrent Diverticulitis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432872/all/Alpha_2__adrenergic_agonists_for_the_management_of_opioid_withdrawal:_Cochrane_systematic_review.
Mesalamine (5‐ASA) for the prevention of recurrent diverticulitis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432872/all/Alpha_2__adrenergic_agonists_for_the_management_of_opioid_withdrawal:_Cochrane_systematic_review. Accessed July 16, 2025.
Mesalamine (5‐ASA) for the prevention of recurrent diverticulitis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432872/all/Alpha_2__adrenergic_agonists_for_the_management_of_opioid_withdrawal:_Cochrane_systematic_review
Mesalamine (5‐ASA) for the Prevention of Recurrent Diverticulitis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 July 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432872/all/Alpha_2__adrenergic_agonists_for_the_management_of_opioid_withdrawal:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mesalamine (5‐ASA) for the prevention of recurrent diverticulitis
ID - 432872
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432872/all/Alpha_2__adrenergic_agonists_for_the_management_of_opioid_withdrawal:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
